According to Zacks, “Dextera Surgical Inc. designs and manufactures proprietary stapling devices for surgical procedures. The company’s product consists of MicroCutter 5/80 use for transection and resection in urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the intestine and the transection of the appendix. Dextera Surgical Inc., formerly known as Cardica Inc., is headquartered in Redwood City, California. “
Shares of Cardica (NASDAQ:DXTR) opened at 1.926 on Tuesday. Cardica has a 52-week low of $1.10 and a 52-week high of $4.30. The company’s market capitalization is $17.14 million. The stock’s 50 day moving average price is $1.91 and its 200-day moving average price is $2.44.
Cardica (NASDAQ:DXTR) last posted its quarterly earnings data on Tuesday, August 9th. The company reported ($0.48) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.47) by $0.01. On average, analysts expect that Cardica will post ($1.53) earnings per share for the current year.
Cardica Company Profile
Dextera Surgical Inc, formerly Cardica, Inc, is focused on the commercialization and development of microcutter product line intended for use by surgeons. The Company is engaged in commercializing and developing MicroCutter XCHANGE 30 based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cardica Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardica Inc. and related companies with MarketBeat.com's FREE daily email newsletter.